Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 287

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 16A
Chunk 287
---

ITEM 16A.   AUDIT COMMITTEE FINANCIAL EXPERT
--------------------------------------------
 
Our board of directors has determined that each of Mr. Dan Falk and Mr. Nir Nimrodi qualifies as an audit committee financial expert, as defined by the rules of the SEC, and has the requisite financial experience required by the Nasdaq Listing Rules. In addition, each of Mr. Falk and Mr. Nimrodi is independent, as such term is defined in Rule 10A-3(b)(1) under the Exchange Act and under the Nasdaq Listing Rules.